Total Brain Limited (TTBLF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Total Brain Limited (TTBLF) trades at $0.0002. Total Brain Limited operates as an applied integrative neuroscience company, providing a mental health monitoring and support platform. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for TTBLF: TTBLF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TTBLF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on TTBLF.
How is this calculated? →Total Brain Limited (TTBLF) Healthcare & Pipeline Overview
Total Brain Limited delivers a mental health monitoring platform leveraging applied integrative neuroscience, serving companies, providers, and precision medicine sectors. With a focus on measuring brain capacities and managing mental health risks, the company operates in the United States and Australia within the evolving healthcare information services landscape.
What Is the Investment Thesis for TTBLF?
Total Brain Limited presents a unique investment proposition within the healthcare information services sector, focusing on mental health monitoring and support. The company's Total Brain platform offers a scalable solution for measuring brain capacities and managing mental health risks, targeting diverse sectors including corporate wellness and precision medicine. Key value drivers include expanding platform adoption, securing strategic partnerships, and demonstrating improved mental health outcomes. Potential catalysts include positive clinical trial results, increased regulatory support for digital mental health solutions, and growing awareness of mental health in the workplace. However, the company faces risks related to market competition, regulatory hurdles, and the need for continuous innovation to maintain its competitive edge. With a negative P/E ratio of -0.01 and a profit margin of -175.6%, the company's path to profitability remains a key consideration for investors. The high gross margin of 90.9% suggests potential for profitability with increased scale and efficient cost management.
Based on FMP financials and quantitative analysis
TTBLF Key Highlights
Total Brain Limited operates in the healthcare information services sector, focusing on mental health monitoring and support.
- The company's core product is the Total Brain platform, which measures brain capacities and helps manage mental health risks.
- Total Brain serves diverse sectors, including companies, providers, affinity groups, and precision medicine.
- The company has a high gross margin of 90.9%, indicating potential for profitability with increased scale.
- Total Brain operates in both the United States and Australia, addressing the growing need for accessible mental health solutions.
Who Are TTBLF's Competitors?
TTBLF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CTBO Cantabio Pharmaceuticals, Inc. | $1.01 | +0.00% | 50 | |
| CMHSF Comprehensive Healthcare Systems, Inc. | $0.31 | +0.00% | $5.62M | 55 |
| CRBKF Carebook Technologies Inc. | $0.03 | +0.00% | $6.84M | 64 |
| CMPD CompuMed, Inc. | $7.25 | -7.70% | $9.35M | 60 |
| BBLN Babylon Holdings Limited | $0.55 | -13.99% | $14.1M | 56 |
| THKKF Think Research Corporation | $0.23 | -1.74% | $17.8M | 57 |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.1M | 67 |
| AIRDF Rocket Doctor AI Inc. | $0.44 | -2.99% | $42.4M | 56 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TTBLF's Key Strengths?
Proprietary Total Brain platform.
- Strong gross margin of 90.9%.
- Presence in US and Australia.
- Diverse customer base.
What Are TTBLF's Weaknesses?
Negative P/E ratio and profit margin.
- Limited brand recognition.
- Reliance on partnerships for market access.
- Potential regulatory hurdles.
What Could Drive TTBLF Stock Higher?
TTBLF catalyst: Positive results from ongoing clinical trials evaluating the efficacy of the Total Brain platform in improving mental health outcomes.
- Increasing adoption of the Total Brain platform within corporate wellness programs, driven by growing awareness of employee mental health.
- Strategic partnerships with healthcare providers to integrate the Total Brain platform into existing clinical workflows.
- Potential regulatory approvals for the Total Brain platform as a medical device or digital therapeutic.
- Expansion into new geographic markets, such as Europe and Asia, to address the growing need for mental health solutions.
What Are the Key Risks for TTBLF?
Intense competition in the digital health market from established players and emerging startups.
- Evolving regulatory landscape for digital health solutions, which could impact the company's ability to market and sell its platform.
- Data privacy and security concerns related to the collection and storage of sensitive mental health data.
- Negative P/E ratio and profit margin, indicating a need to improve financial performance.
- Limited brand recognition, which could hinder the company's ability to attract new customers.
What Are the Growth Opportunities for TTBLF?
- Expansion into Corporate Wellness Programs: Total Brain can capitalize on the growing emphasis on employee mental health by expanding its platform's adoption within corporate wellness programs. The global corporate wellness market is projected to reach $84.6 billion by 2027, presenting a significant opportunity for Total Brain to offer its mental health monitoring and support platform to a broader corporate audience. This expansion can be achieved through strategic partnerships with HR technology providers and targeted marketing campaigns highlighting the platform's benefits in improving employee productivity and reducing healthcare costs. Timeline: Ongoing.
- Strategic Partnerships with Healthcare Providers: Collaborating with healthcare providers, including hospitals and clinics, can significantly expand Total Brain's reach and credibility. By integrating the Total Brain platform into existing healthcare workflows, the company can offer clinicians valuable data-driven insights to support diagnosis and treatment decisions. The market for digital health solutions in healthcare is expected to grow substantially, driven by the increasing adoption of telehealth and remote patient monitoring. Timeline: Ongoing.
- Development of Personalized Mental Health Interventions: Leveraging the data collected through the Total Brain platform, the company can develop personalized mental health interventions tailored to individual needs. This can involve creating customized training programs, recommending specific therapeutic activities, and providing targeted support based on individual brain capacity measurements. The personalized medicine market is experiencing rapid growth, driven by advances in data analytics and artificial intelligence. Timeline: Ongoing.
- Geographic Expansion into New Markets: Total Brain can explore opportunities to expand its operations into new geographic markets beyond the United States and Australia. Regions with a high prevalence of mental health issues and a growing adoption of digital health solutions, such as Europe and Asia, represent attractive expansion targets. This expansion can be achieved through strategic partnerships with local healthcare providers and targeted marketing campaigns tailored to regional needs. Timeline: 2027-2028.
- Integration with Wearable Technology: Integrating the Total Brain platform with wearable technology, such as smartwatches and fitness trackers, can provide users with continuous mental health monitoring and real-time feedback. This integration can enhance the platform's usability and accessibility, making it easier for users to track their mental well-being and receive timely support. The market for wearable technology is experiencing rapid growth, driven by increasing consumer awareness of health and fitness. Timeline: 2027.
What Are TTBLF's Competitive Advantages?
- Proprietary mental health monitoring platform based on neuroscience.
- Data-driven insights into brain capacities and mental health risks.
- Established presence in the United States and Australia.
- Diverse customer base across multiple sectors.
What Does TTBLF Do?
Total Brain Limited, founded in 2000 and based in Surry Hills, Australia, operates as an applied integrative neuroscience company. Originally named Brain Resource Limited, the company rebranded to Total Brain Limited in December 2018 to better reflect its focus on mental health solutions. The company's core offering is the Total Brain platform, a mental health monitoring and support system designed to help users measure their brain capacities and manage the risk of common mental conditions. This platform serves a diverse range of clients, including companies looking to support employee mental health, healthcare providers seeking advanced diagnostic tools, affinity groups aiming to improve member well-being, and precision medicine sectors focused on personalized treatment approaches. Total Brain operates in both the United States and Australia, addressing the growing need for accessible and effective mental health solutions in these markets. The company's approach integrates neuroscience with technology to provide data-driven insights into mental well-being, differentiating it from traditional mental healthcare models.
What Products and Services Does TTBLF Offer?
- Offers the Total Brain platform for mental health monitoring and support.
- Helps users measure their brain capacities.
- Manages the risk of common mental conditions.
- Serves companies with employee mental health programs.
- Provides tools for healthcare providers for advanced diagnostics.
- Supports affinity groups to improve member well-being.
- Offers solutions for precision medicine sectors for personalized treatment.
How Does TTBLF Make Money?
- Subscription-based access to the Total Brain platform.
- Partnerships with companies for employee mental health programs.
- Licensing agreements with healthcare providers.
- Data analytics and insights services.
What Industry Does TTBLF Operate In?
The healthcare information services industry is experiencing rapid growth, driven by increasing demand for digital health solutions and personalized medicine. Mental health is becoming a key focus, with companies and healthcare providers seeking innovative ways to support well-being. Total Brain Limited operates within this evolving landscape, offering a platform that integrates neuroscience with technology to provide data-driven insights into mental health. Competitors include companies like CBDHF (CloudMD Software & Services Inc.), CTBO (Castro Capital Corp.), DGCRF (Data Knights Acquisition Corp.), HGENQ (Hydrogenetics Corporation), and MOSTQ (Mostostal Plock SA), each with varying approaches to mental health and wellness. The market is characterized by increasing investment in digital mental health solutions and a growing emphasis on preventative care.
Who Are TTBLF's Key Customers?
- Companies seeking to improve employee mental health and productivity.
- Healthcare providers looking for advanced diagnostic tools.
- Affinity groups aiming to enhance member well-being.
- Precision medicine sectors focused on personalized treatment approaches.
Company Profile
Total Brain Limited operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Surry Hills, AU. The company is led by CEO Matthew Mund. TTBLF has traded publicly since 2013.
TTBLF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Total Brain's future prospects, which can be a positive signal for investors.
- Community sentiment has shown increased optimism, driven by recent product updates that align with mental health trends.
- Analysts are noting the growing demand for mental health solutions, positioning Total Brain favorably within a booming market.
- The company's strategic partnerships in the wellness sector have enhanced its visibility and credibility among consumers.
Bear Case
- Concerns over market competition are rising, as several new entrants are emerging in the mental wellness space.
- Social sentiment has also reflected skepticism about the company's ability to scale its user base effectively in a crowded market.
- Recent reports indicate challenges in monetizing their platform, which could impact long-term profitability.
- The overall market sentiment has been cautious, influenced by broader economic uncertainties that may affect consumer spending on wellness services.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
TTBLF Latest News
No recent news available for TTBLF.
TTBLF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TTBLF.
Price Targets
Wall Street price target analysis for TTBLF.
TTBLF MoonshotScore
What does this score mean?
The MoonshotScore rates TTBLF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Matthew Mund
CEO
Matthew Mund serves as the CEO of Total Brain Limited. His background encompasses leadership roles within the technology and healthcare sectors, focusing on driving innovation and strategic growth. He has a proven track record of building and scaling businesses, with expertise in product development, market expansion, and customer engagement. His experience includes leading cross-functional teams and fostering a culture of innovation to deliver impactful solutions to the market. He brings a wealth of knowledge in digital health and neuroscience to Total Brain.
Track Record: Under Matthew Mund's leadership, Total Brain Limited has focused on expanding the reach and capabilities of its mental health monitoring platform. Key achievements include securing strategic partnerships with healthcare providers and corporate clients, enhancing the platform's data analytics capabilities, and driving increased user engagement. He has overseen the company's efforts to develop personalized mental health interventions and expand into new geographic markets. His strategic decisions have aimed to position Total Brain as a leader in the digital mental health space.
TTBLF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Total Brain Limited may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting or may be undergoing financial distress. Investing in companies on the OTC Other tier carries significant risks due to the lack of regulatory oversight and potential for fraud or manipulation. Investors should exercise extreme caution and conduct thorough due diligence before investing in OTC Other stocks. These securities often have very low trading volume and wide bid-ask spreads, making it difficult to buy or sell shares at desired prices.
- OTC Tier: OTC Other
- Limited financial disclosure increases information asymmetry.
- Low trading volume and wide bid-ask spreads can lead to difficulty in buying or selling shares.
- Higher potential for fraud or manipulation due to less regulatory oversight.
- OTC Other companies may be undergoing financial distress or have limited operating history.
- Delisting risk is higher compared to stocks on major exchanges.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's cash flow and ability to meet its financial obligations.
- Check for any legal or regulatory issues involving the company.
- Understand the risks associated with investing in OTC stocks.
- Consult with a qualified financial advisor.
- Company has been in operation since 2000.
- Operates in the healthcare sector, which is subject to some regulatory oversight.
- Has a clearly defined business model with a focus on mental health monitoring.
- Serves a diverse customer base, including companies and healthcare providers.
Common Questions About TTBLF (Healthcare)
What does Total Brain Limited do?
Total Brain Limited operates as an applied integrative neuroscience company, offering the Total Brain platform for mental health monitoring and support. The platform helps users measure their brain capacities and manage the risk of common mental conditions. It serves companies, healthcare providers, affinity groups, and precision medicine sectors, providing data-driven insights into mental well-being.
What do analysts say about TTBLF stock?
As of March 16, 2026, there is no readily available analyst consensus on Total Brain Limited (TTBLF) due to its OTC listing and limited coverage. Key valuation metrics such as P/E ratio (-0.01) and profit margin (-175.6%) indicate that the company is currently not profitable.
What are the main risks for TTBLF?
Total Brain Limited faces several risks, including intense competition in the digital health market, evolving regulatory landscape for digital health solutions, and data privacy and security concerns related to the collection and storage of sensitive mental health data. The company's negative P/E ratio and profit margin indicate a need to improve financial performance.
What are the key factors to evaluate for TTBLF?
Evaluate TTBLF on fundamentals, analyst consensus, and risk factors. Total Brain Limited presents a unique investment proposition within the healthcare information services sector, focusing on mental health monitoring and support. Not financial advice.
How frequently does TTBLF data refresh on this page?
TTBLF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven TTBLF's recent stock price performance?
Total Brain Limited (TTBLF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary Total Brain platform. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider TTBLF overvalued or undervalued right now?
Total Brain Limited (TTBLF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research TTBLF before investing?
Before investing in Total Brain Limited (TTBLF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.
- AI analysis pending for TTBLF, which may provide further insights.